Shanghai Henlius Biotech, Inc.

SSE
2696
Stock
Yield per half year: 0%
Dividend yield: 0%
Sector: Healthcare

Reporting Shanghai Henlius Biotech, Inc.

Capitalization

IFRS
Reporting Annual
LTM 5 year average CAGR 5
Капитализация, млрд ¥
6.1
Выручка, млрд ¥
3.21
Чистая прибыль, млрд ¥
-0.6953
EV, млрд ¥
9.18
EBITDA, млрд ¥
-0.2208


Balance sheet

IFRS
Reporting Annual
LTM 5 year average CAGR 5
Наличность, млрд ¥
0.8721
Долг, млрд ¥
3.68


Share

IFRS
Reporting Annual
LTM 5 year average CAGR 5
EPS -1.39


Efficiency

IFRS
Reporting Annual Quarterly
2023 2024 2025 LTM Industry average 5 year average CAGR 5
ROE, % -35.35 7.46
ROA, % -3.33 4.02
ROS, % -21.66 -21.66 -21.66 -21.66 8.61 -21.6600 0.00
ROCE, % 0 0 0.00
Ebit margin, % 0 0
Рентаб EBITDA, % -6.88 -6.88 -211.49 -6.8800 0.00
Чистая рентаб, % -21.63 8.61
Operation Margin, % 0 0 0 0 5.16


Coefficients

IFRS
Reporting Annual Quarterly
2023 2024 2025 LTM Industry average 5 year average CAGR 5
P/BV
3.44 3.78
P/S
1.75 13.31
P/FCF
0 0 0 0 -41.53
E/P
-0.114 -0.114 -0.114 -0.114 0.03 -0.1140 0.00
EV/EBIT
0 0 0
EV/EBITDA
-29.54 19.30
EV/S
2.86 2.86 2.86 2.86 43.18 2.86 0.00
EV/FCF
0 0 0 -45.85
Debt/EBITDA
-16.67 -16.67 -16.67 -16.67 1.87 -16.6700 0.00
Netdebt/Ebitda
0 0 0 0 0.24
Debt/Ratio
0 0 0 0 0.08
Debt/Equity
0 0 0 0 0.45
Debt/Net Income
-5.29 -5.29 -5.29 -5.29 3.11 -5.2900 0.00
PEG
0 0
Бета
0 0 0 0 0.44
Индекс Альтмана
0 0 0 0 5.11


Dividends

IFRS
Reporting Annual
LTM Industry average 5 year average CAGR 5
Дивиденды / прибыль, %
0 69.64


Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription

Subscribe

Other

IFRS
Reporting Annual
2023 2024 CAGR 5
Персонал, чел
3 406 3 637 3.34